Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 2;21(7):615-622.
doi: 10.1080/15384047.2020.1740054. Epub 2020 Apr 26.

LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2

Affiliations

LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2

Haixia Li et al. Cancer Biol Ther. .

Abstract

Acute myeloid leukemia (AML) is a prevalent class of blood disease with a high occurrence rate and relapse rate. The role of dysregulated microRNAs (miRNAs) in AML is emerging. MiR-4260 was identified to be a carcinogenic miRNA in colorectal cancer, but never has it been reported in AML. We aimed to study the function and mechanism of miR-4260 in AML. The miR-4260 level was higher in AML cell lines than the normal cell lines. Inhibition of miR-4260 hindered proliferation and increased apoptosis of AML cells. Mechanistically, long intergenic non-protein coding RNA 1128 (LINC01128) competed with nuclear receptor subfamily 3 group C member 2 (NR3C2) for miR-4260 so as to upregulate NR3C2. We identified the reduced levels of LINC01128 and NR3C2 in AML and it was suggested through rescue assays that LINC01128 repressed AML progression through regulating miR-4260/NR3C2 axis. In conclusion, we firstly uncovered that LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2, providing novel clues for the treatment improvement of AML.

Keywords: AML; LINC01128; NR3C2; miR-4260.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Expression and function of miR-4260 in AML.
Figure 2.
Figure 2.
LINC01128 could sponge miR-4260 in AML.
Figure 3.
Figure 3.
LINC01128 upregulated NR3C2 by targeting miR-4260 in AML.
Figure 4.
Figure 4.
Role of LINC01128/miR-4260/NR3C2 axis in AML.

References

    1. Somintara S, Leardkamolkarn V, Suttiarporn P, Mahatheeranont S.. Anti-tumor and immune enhancing activities of rice bran gramisterol on acute myelogenous leukemia. PLoS One. 2016;11:e0146869–e. doi:10.1371/journal.pone.0146869. - DOI - PMC - PubMed
    1. Bi L, Sun L, Jin Z, Zhang S, Shen Z.. MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia. Oncol Lett. 2018;15:5611–5619. doi:10.3892/ol.2018.8050. - DOI - PMC - PubMed
    1. Li S, Mason CE, Melnick A. Genetic and epigenetic heterogeneity in acute myeloid leukemia. Curr Opin Genet Dev. 2016;36:100–106. doi:10.1016/j.gde.2016.03.011. - DOI - PMC - PubMed
    1. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89–101. doi:10.1038/nrc989. - DOI - PubMed
    1. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13:e249–e58. doi:10.1016/S1470-2045(12)70073-6. - DOI - PubMed

Publication types